Literature DB >> 35121808

HLA-haploidentical donor transplants with post-transplant cyclophosphamide in children with primary immune deficiency disorders.

Hawazen AlSaedi1, Reem Mohammed2, Khawar Siddiqui3, Ali Al-Ahmari3, Bandar AlSaud2, Hamoud Almousa2, Abdullah Al-Jefri3, Ibrahim Ghemlas3, Awatif AlAnazi3, Amal Al-Seraihy3, Hassan El-Solh3, Mouhab Ayas3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35121808     DOI： 10.1038/s41409-022-01589-7

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  5 in total

1.  T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation.

Authors:  Asad Bashey; Xu Zhang; Connie A Sizemore; Karen Manion; Stacey Brown; H Kent Holland; Lawrence E Morris; Scott R Solomon
Journal:  J Clin Oncol       Date:  2013-02-19       Impact factor: 44.544

Review 2.  High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation.

Authors:  Leo Luznik; Ephraim J Fuchs
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

3.  Posttransplant cyclophosphamide for haploidentical stem cell transplantation in children with Wiskott-Aldrich syndrome.

Authors:  Yan Yue; Xiaodong Shi; Zeliang Song; Jiayue Qin; Junhui Li; Shunqiao Feng; Rong Liu
Journal:  Pediatr Blood Cancer       Date:  2018-05-10       Impact factor: 3.167

Review 4.  Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives.

Authors:  Riccardo Castagnoli; Ottavia Maria Delmonte; Enrica Calzoni; Luigi Daniele Notarangelo
Journal:  Front Pediatr       Date:  2019-08-08       Impact factor: 3.418

5.  Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Primary Immune Deficiency Disorders in Children: Challenges and Outcome from a Tertiary Care Center in South India.

Authors:  Ramya Uppuluri; Meena Sivasankaran; Shivani Patel; Venkateswaran Vellaichamy Swaminathan; Kesavan Melarcode Ramanan; Nikila Ravichandran; Balasubramaniam Ramakrishnan; Indira Jayakumar; Lakshman Vaidhyanathan; Revathi Raj
Journal:  J Clin Immunol       Date:  2019-02-18       Impact factor: 8.317
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.